Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -36.10x is 11% above its 1-year average of -40.36x, near the high end of its 1-year range (-44.61x–-36.10x).
As of the fiscal period ended Monday, September 30, 2024.
Reported quarterly interest coverage; no daily interpolation.
Limited quarterly history available
Interest Coverage needs at least three reported quarters before a meaningful chart is shown.
INTEREST COVERAGE RATIO
-36.10x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.42x
median of 428 covered companies
CURRENT VS SECTOR MEDIAN
-566.04%
vs the sector median at left
eXoZymes, Inc.
Market Cap
$51.98M
Interest Coverage Ratio
-36.10x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$51.83M
Interest Coverage Ratio
3.24x
TTM Avg
3.06x
3Y Avg
3.54x
5Y Avg
8.88x
Market Cap
$52.26M
Interest Coverage Ratio
-557.72x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$52.37M
Interest Coverage Ratio
-6.14x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$51.45M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$51.39M
Interest Coverage Ratio
-145.74x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$51.33M
Interest Coverage Ratio
-14.01x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$50.81M
Interest Coverage Ratio
N/A
TTM Avg
254.37x
3Y Avg
222.37x
5Y Avg
222.37x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| eXoZymes, Inc. (EXOZ) | $51.98M | -36.10x | N/A | N/A | N/A |
| biote Corp. (BTMD)vs › | $51.83M | 3.24x | 3.06x | 3.54x | 8.88x |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $52.26M | -557.72x | N/A | N/A | N/A |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $52.37M | -6.14x | N/A | N/A | N/A |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $51.45M | N/A | N/A | N/A | N/A |
| Apollomics, Inc. (APLM)vs › | $51.39M | -145.74x | N/A | N/A | N/A |
| Envoy Medical, Inc. (COCH)vs › | $51.33M | -14.01x | N/A | N/A | N/A |
| INmune Bio, Inc. (INMB)vs › | $51.18M | N/A | N/A | N/A | N/A |
| Microbot Medical Inc. (MBOT)vs › | $50.81M | N/A | 254.37x | 222.37x | 222.37x |
| Clene Inc. (CLNN)vs › | $50.47M | -8.61x | N/A | N/A | N/A |
Interest Coverage
-36.1x
Debt/Equity
0.30
Current Ratio
3.81
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2024-09-30 | -36.10x |
| 2024-06-30 | -44.61x |
